Gestalt Diagnostics and Flagship Biosciences today announced their collaboration in the development of an integrated workflow for pathologists to access Flagship’s Image Analysis services for digital images to support PD-L1 testing.The companies are providing a more efficient diagnostic process by engaging in a shared service to add Flagship’s computational services to Gestalt’s digital pathology solution, PathFlow™.
“Our relationship with Flagship Biosciences, and the resulting automated and streamlined workflow
for PD-L1 cases is another step forward in our digital platform,” says Gestalt COO & Chief Strategy
Officer, Lisa-Jean Clifford. “This new relationship is giving pathologists access to the automation and
tools that will continue to increase their efficiency, minimizing the manual steps in their case work. We
are pleased to partner with Flagship Biosciences to integrate their machine learning/AI tools to
provide cancer marker detection.”
“Our goal is to provide a more streamlined workflow for pathologists as well as provide more insight
for oncologists through our computational services. We’re pleased to be partnering with Gestalt to
advance the state of diagnostics through the use of image analysis,” said Trevor Johnson, Flagship
Bioscience’s CEO.
Gestalt’s PathFlow™ users will have the ability to directly request the PD-L1 image analysis service
from within the interface. A consistent PD-L1 report and images are returned and loaded into the case
file for final review.
Visit Gestalt at the Pathology Visions conference Oct 6-9, 2019 in booth #302 to learn more.
About Gestalt Diagnostics
Gestalt Diagnostics is a private, profit-driven software company who provides technology solutions,
technical and integration services and support to pathology laboratories. Gestalt has developed
PathFlow, an enterprise software platform specifically designed to bring the benefits of digital
workflow to pathologists and pathology laboratories. This product was originally developed, by
what is now Gestalt’s team, to support a fully digital reading platform for radiology. The
radiology platform is used in leading hospitals across the United States and supports more
than 15 million studies annually. Gestalt has expanded and redesigned this proven, robust
solution to work in the laboratory space – engineered for the unique needs and workflow of
pathologists.
About Flagship Biosciences
Flagship Biosciences, Inc. is a technology-driven tissue analysis services company delivering the
most accurate and informative data for improved therapeutic development and diagnostics.
The company offers a full range of tissue analysis services using its award-winning technology,
to help accelerate drug development and create more accurate diagnostic tests, supported by a team
of experienced pathology and scientific experts. Flagship Biosciences, Inc. was founded in 2009 and
is headquartered in Westminster, Colorado. To learn more, please visit www.flagshipbio.com
